RESUMO
The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.
Assuntos
Antipsicóticos , População Australasiana , Transtornos Psicóticos , Esquizofrenia , Humanos , Antipsicóticos/uso terapêutico , Esquizofrenia/tratamento farmacológico , Austrália , Transtornos Psicóticos/tratamento farmacológicoRESUMO
The study of human behavior during and following disasters can provide valuable insights into the psychology of coping, particularly in extreme environmental circumstances and can provide clues about the etiology of psychiatric disorders. The nature of the crisis, the extent of the personal distress, and the helplessness of individuals affected, make those afflicted by disaster a particularly vulnerable group, whose distress may be increased by the researcher